1
Rajinder Singh, Ankush Argade, Donald Payan, Susan Molineaux, Sacha J Holland, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Catherine Sylvain, Hui Li, Alexander B Rossi: Intermediates useful for making 2,4-pyrimidinediamine compounds. Rigel Pharmaceuticals, Dechert, June 13, 2006: US07060827 (128 worldwide citation)

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in ...


2
Rajinder Singh, Ankush Argade, Hui Li, Somasekhar Bhamidipati, David Carroll, Catherine Sylvain, Jeffrey Clough, Holger Keim: Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds. Rigel Pharmaceuticals, Dechert, October 17, 2006: US07122542 (125 worldwide citation)

The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with ...


3
Rajinder Singh, Ankush Argade, Donald Payan, Susan Molineaux, Sacha J Holland, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Catherine Sylvain, Hui Li, Alexander B Rossi: 2,4-pyrimidinediamine compounds and their uses. Rigel Pharmaceuticals, Foley & Lardner, James J Diehl, Brian D Griedel, February 19, 2008: US07332484 (79 worldwide citation)

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in ...


4
Rajinder Singh, Ankush Argade, Donald Payan, Susan Molineaux, Sacha J Holland, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Catherine Sylvain, Hui Li, Alexander B Rossi: 2,4-pyrimidinediamine compounds and their uses. Rigel Pharmaceuticals, Foley & Lardner, James J Diehl, July 7, 2009: US07557210 (76 worldwide citation)

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in ...


5
Rajinder Singh, Ankush Argade, Donald Payan, Susan Molineaux, Sacha J Holland, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Catherine Sylvain, Hui Li, Alexander B Rossi: 2,4-pyrimidinediamine compounds and their uses. Rigel Pharmaceuticals, Foley & Lardner, James J Diehl, Brian D Griedel, February 12, 2008: US07329671 (76 worldwide citation)

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in ...


6
Rajinder Singh, Ankush Argade, Donald Payan, Susan Molineaux, Sacha J Holland, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Catherine Sylvain, Hui Li, Alexander B Rossi: 2,4-pyrimidinediamine compounds and their uses. Rigel Pharmaceuticals, Foley & Lardner, James J Diehl, Brian D Griedel, February 12, 2008: US07329672 (70 worldwide citation)

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in ...


7
Rajinder Singh, Ankush Argade, Hui Li, Somasekhar Bhamidipati, David Carroll, Catherine Sylvain, Jeffrey Clough, Holger Keim: Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds. Rigel Pharmaceuticals, Foley & Lardner, James J Diehl, November 18, 2008: US07452879 (68 worldwide citation)

The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with ...


8
Rajinder Singh, Ankush Argade, Hui Li, Holger Keim: Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds. Rigel Pharmaceuticals, McDonnell Boehnen Hulbert & Berghoff, September 1, 2009: US07582648 (67 worldwide citation)

The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with ...


9
Rajinder Singh, Ankush Argade, Donald Payan, Susan Molineaux, Sacha J Holland, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Catherine Sylvain, Hui Li, Alexander B Rossi: 2,4-pyrimidinediamine compounds and their uses. Rigel Pharmaceuticals, Foley & Lardner, James J Diehl, February 3, 2009: US07485724 (67 worldwide citation)

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in ...


10
Rajinder Singh, Ankush Argade, Donald G Payan, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Catherine Sylvain, Hui Li: Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds. Rigel Pharmaceuticals, Foley & Lardner, James J Diehl, April 14, 2009: US07517886 (64 worldwide citation)

The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with ...